Results 211 to 220 of about 61,179 (292)

Insights on genomic profiles of drug resistance and virulence in a cohort of Leishmania infantum isolates from the Mediterranean area. [PDF]

Parasit Vectors
Carrasco-Martin M, Martí-Carreras J, Gómez-Ponce M, Alcover MM, Roura X, Ferrer L, Baneth G, Bruno F, Chicharro C, Cordeiro-da-Silva A, Cristovão J, Di Muccio T, Maia C, Moreno J, Priego A, Roca-Geronès X, Santarem N, Soriano AV, Vitale F, Yasur-Landau D, Francino O.   +20 more
europepmc   +1 more source

HLA ‐ B *58:01 is strongly associated with allopurinol‐induced severe cutaneous adverse reactions in H an C hinese patients: a multicentre retrospective case–control clinical study [PDF]

, 2015
Lin Cheng, Yan Xiong, Chunxiang Qin, W. Zhang, Xiaoyang Chen, J. Li, Hong‐Hao Zhou   +6 more
openalex   +1 more source

Miltefosine in visceral leishmaniasis.

, 2003
Bryceson, Anthony DM, Engel, Jurgen, Olliaro, Piero L, Ridley, Robert G, Sindermann, Herbert   +4 more
core   +1 more source

Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study. [PDF]

Cureus
Voskamp J, Tausche AK.
europepmc   +1 more source

Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity

, 2017
Andrija Šmelcerović, Katarina Tomović, Žaklina Šmelcerović, Živomir Petronijević, Gordana Kocić, Tihomir Tomašič, Žiga Jakopin, Marko Anderluh   +7 more
openalex   +1 more source

PMS15 Cost Analysis of Febuxostat Versus Allopurinol for Prophylaxis of Gout Flares [PDF]

, 2012
T. Jackson, Ruchit Shah
openalex   +1 more source

Dual-drug nanocarriers for gout therapy: targeted co-delivery of anti-inflammatory and urate-lowering agents: a review. [PDF]

EXCLI J
Karusan NR, Tajuddin HA, Mat Radi NA, Karimah R, Soesilawati P, Mahmood S, Ahmad N.   +6 more
europepmc   +1 more source

Reply to “Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!” by Stamp et al.

, 2019
Solène M. Laville, Bénédicte Stengel, Ziad A. Massy, Sophie Liabeuf   +3 more
openalex   +2 more sources

DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) Is More: A Rare Case of Acalculous Cholecystitis. [PDF]

ACG Case Rep J
Gupta SR, Chang A, Farrakhan K, Guo A, Nowrangi D, Moss SF.   +5 more
europepmc   +1 more source

HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US.

JAMA Dermatol
Campbell CN, Krantz MS, Yu A, Phillips EJ, Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Survivor Study Collaborators.   +4 more
europepmc   +1 more source